Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer
11 avr. 2019 10h01 HE
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Surrozen Inc., a company discovering and developing novel antibodies for regenerative medicine with a focus on specific control of the...
Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidates
14 mars 2019 10h00 HE
|
Surrozen, Inc.
-- Anna Berkenblit, MD, appointed to Surrozen Board of Directors -- SAN FRANCISCO, March 14, 2019 (GLOBE NEWSWIRE) -- Surrozen Inc., a company discovering and developing novel antibodies for...